Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 94, Issue 9, Pages 950-965
Publisher
Springer Nature
Online
2014-07-28
DOI
10.1038/labinvest.2014.89
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The application of Heck reaction in the synthesis of guaianolide sesquiterpene lactones derivatives selectively inhibiting resistant acute leukemic cells
- (2013) Ya-Hui Ding et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis of Micheliolide Derivatives and Their Activities against AML Progenitor Cells
- (2013) Wei-Wei Ma et al. MOLECULES
- Guaianolide Sesquiterpene Lactones, a Source To Discover Agents That Selectively Inhibit Acute Myelogenous Leukemia Stem and Progenitor Cells
- (2012) Quan Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biomimetic Semisynthesis of Arglabin from Parthenolide
- (2012) Jia-Dai Zhai et al. JOURNAL OF ORGANIC CHEMISTRY
- Risk of Infection and Prevention in Pediatric Patients With IBD
- (2012) Gigi Veereman-Wauters et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation
- (2012) Benoit Chassaing et al. PLoS One
- Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease
- (2011) C. Steenholdt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Experimental Inflammatory Bowel Disease: Insights into the Host-Microbiota Dialog
- (2011) Maya Saleh et al. IMMUNITY
- Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates dextran sulfate sodium-induced colitis in mice
- (2011) Zhi Jing Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Genetics and pathogenesis of inflammatory bowel disease
- (2011) Bernard Khor et al. NATURE
- Inflammation and Colon Cancer
- (2010) Janoš Terzić et al. GASTROENTEROLOGY
- Cancer in Crohnʼs Disease patients treated with infliximab: A long-term multicenter matched pair study
- (2010) Livia Biancone et al. INFLAMMATORY BOWEL DISEASES
- Severe neutropenia following infliximab treatment in a child with ulcerative colitis
- (2010) Mary Sherlock et al. INFLAMMATORY BOWEL DISEASES
- A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-κB and generating reactive oxygen species
- (2010) Rajasubramaniam Shanmugam et al. INTERNATIONAL JOURNAL OF CANCER
- Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect
- (2010) Marisa Iborra et al. Journal of Crohns & Colitis
- A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFκB and generating reactive oxygen species
- (2010) Rajasubramaniam Shanmugam et al. PROSTATE
- Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
- (2009) S. SCHNEEWEISS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-κB inhibitor, DMAPT (LC-1)
- (2009) Sundar Neelakantan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse Model
- (2009) Hamed Laroui et al. GASTROENTEROLOGY
- Effect of Celecoxib and the Novel Anti-Cancer Agent, Dimethylamino-Parthenolide, in a Developmental Model of Pancreatic Cancer
- (2008) Michele T. Yip-Schneider et al. PANCREAS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now